Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

46 filings reported holding TERN - Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q2 2022.
Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.7M shares of 87.4M outstanding shares and own 16.8% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.79M shares), Vivo Capital, LLC (2.68M shares), RA CAPITAL MANAGEMENT, L.P. (1.26M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.24M shares), Antara Capital LP (875K shares), Decheng Capital Management III (Cayman), LLC (714K shares), Ikarian Capital, LLC (700K shares), Point72 Asset Management, L.P. (500K shares), Affinity Asset Advisors, LLC (401K shares), and VANGUARD GROUP INC (368K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.